← Evidence map

ReviewFrontiers in microbiology2025

CRISPR-Cas systems against carbapenem resistance: from proof-of-concept to clinical translation.

Pandora Jim TsolakidouPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

8 papers cite it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 41488303